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Drink responsibly! Rapid regression of 
fatty liver disease on enhanced CT after 
alcohol withdrawal
T. Kirchgesner1, E. Danse1
A 50-year-old woman is admitted in Emergency Room for acute 
epigastric pain. She acknowledges the consumption of 6 to 7 beers 
per day last days before admission (8 to 10 alcohol units per day). 
Blood  samples demonstrate inflammation (CRP: 5,2 mg/dL), hepa-
tocytes cytolysis (AST 3 times higher than normal, ALT 2 times 
higher than normal and GGT 20 times higher than normal) and 
 hyperlipasemia (15 times higher than normal). Diagnosis is obvi-
ous based on clinic and biology, which is confirmed the same day 
by an enhanced CT at portal venous phase demonstrating an acute 
pancreatitis graded D according to Balthazar scoring (Fig. A). After 
9 days of  hospitalization a follow up CT is performed in the exact 
same conditions (Fig. B).
Comment
Admission CT shows deep fatty liver disease (FLD) characterized 
by a «dark liver» aspect because of fat infiltration. Follow up CT 
performed in the same conditions after 9 days of complete alcohol 
withdrawal demonstrates significative regression of FLD with liver 
density approaching spleen density and tending to normal. Liver 
densities are respectively 31 Hounsfield Units (HU) and 105 HU on 
first and second CT while differences between liver and spleen 
 densities are respectively -84 HU and -24 HU.
Liver biopsy is the gold-standard exam for FLD diagnosis and quantification, but this technique is invasive with a 
morbidity rate of 1-3% and a mortality rate of 0,01-0,03%, so that medical imaging is in the front line to identify pa-
tients with steatosis and orientate them toward biopsy if necessary (1). On CT FLD is responsible of a “dark liver” as-
pect: without contrast liver density 10 HU lower than spleen density is highly suggestive of fatty infiltration (sensitiv-
ity of 84% and specificity of 99%) whereas at portal venous phase liver density 20 HU lower than spleen density has a 
sensitivity of 86-87% and a specificity of 75-87% for FLD diagnosis. At portal venous phase liver density inferior to 40 
HU is also a good indicator of FLD. MRI is considered as the most performant imaging method to assess and quantify 
fatty liver infiltration: several protocols including in-phase/out-of-phase imaging, fat saturation imaging and magnetic 
resonance spectroscopy (MRS) are currently in use for both detection and quantification of FLD. Recently MRS that 
directly measures proton signals from the acyl groups in hepatocyte triglyceride stores has shown accuracy for diag-
nosing and quantifying FLD and may be replacing liver biopsy as the new gold standard (1). Ultrasonography is non 
irradiant, available and low cost compared to MRI. Whereas FLD is characterized by a «dark liver» aspect in CT, US 
demonstrates a «bright liver» with increased echogenicity compared to right kidney cortex. Recent studies demon-
strated the possibility to quantify FLD with B-mode ultrasound and computer analysis, while others demonstrated the 
efficiency of methods based on transient elastography (Fibrosan®) to evaluate steatosis as fibrosis (1).
This case demonstrates on one hand the reversibility of FLD if underlying cause is treated and on the  other hand 
the possible rapidity of the regression process in less than ten days. We sincerely hope this  report will encourage 
physicians to support abusive drinker patients to lower their alcoholic beverages  consumption before irreversible 
damages  occur.
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